DEVELOPMENT AGREEMENTDevelopment Agreement • August 9th, 2023 • Cardiff Oncology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 9th, 2023 Company Industry JurisdictionThis Development Agreement (“Agreement”) is made as of this 30th day of June, 2023 (the “Effective Date”) by and between Cardiff Oncology, Inc., a corporation formed under the laws of Delaware and having a principal place of business at 11055 Flintkote Avenue, San Diego, CA 92121 (“Company”) and Pfizer Inc., a Corporation formed under the laws of Delaware and having a principal place of business at 66 Hudson Boulevard East, New York, NY 10001-2192, on behalf of itself and any one or more of its Affiliates that conducts activities hereunder (collectively, “Pfizer” and along with Company, the “Parties” and each, a “Party”).